Universe Pharmaceuticals INC (UPC) Form 10-K Annual Reports
Universe Pharmaceuticals INC (UPC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: UPC
CIK: 1809616
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: F4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
ENROME LLP
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerWai Fok
Audit LocationSingapore, Singapore
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003207 | View SEC Doc Filr Page |
| 6-K | 2026-10-06 | 2026-10-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107197 | View SEC Doc Filr Page |
| F-3 | 2026-09-29 | — | REGISTRATION STATEMENT | 0001213900-26-104659 | View SEC Doc Filr Page |
| 6-K/A | 2026-09-03 | 2026-09-03 | AMENDMENT NO. 1 TO FORM 6-K | 0001213900-26-097225 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096340 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096339 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096336 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096335 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096334 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096333 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096332 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-01 | — | SCHEDULE 13G Filing | 0001213900-26-096331 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096306 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083956 | View SEC Doc Filr Page |
| 6-K | 2026-07-29 | 2026-03-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082789 | View SEC Doc Filr Page |
| 6-K | 2026-06-26 | 2026-06-26 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-072603 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-07 | 4 Filing | 0001213900-26-060060 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-21 | — | SCHEDULE 13D Filing | 0001213900-26-060059 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-056617 | View SEC Doc Filr Page |
| 6-K | 2026-04-16 | 2026-04-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-044641 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029879 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029872 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029865 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029857 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029851 | View SEC Doc Filr Page |